| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1671 |
| Trial ID | NCT02963038 |
| Disease | B-Cell Leukemia | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | SenL_19 |
| Generation | 3rd |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | CAR T Cells for Refractory B Cell Malignancy |
| Year | 2016 |
| Country | China |
| Company sponsor | Hebei Senlang Biotechnology Inc., Ltd. |
| Other ID(s) | SenL_19 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||